products investigational treatment dose drug study days therapy weeks allergic 
agent investigational days received enrollment prior use randomization treatment therapeutic 
myelosuppressive nitrosourea chemotherapy weeks received prior days study enrollment dose 
infusion lymphocyte donor dli days cell received prior infusions enrollment 
experimental drug therapy study days use weeks treatment prior baseline 
month prior treatment study enrollment therapy radiation use received past 
drugs investigational days received enrollment patient study use prior dose 
anticancer therapy investigational receipt treatment study systemic prior days drug 
agent investigational type dose received days treatment study subject drug 
infection requiring drug completed systemic recent dose days treatment study 
bleomycin prior treatment radiosurgery chemotherapy use enrollment contraindicates morbid agent 
sex having condom woman use drug study pregnant agrees dose 
investigational drug days treatment study prior dose received enrollment use 
